RE:RE:RevenuesOk, but if revenues are mostly generated due to covid-19, they even said it's temporary. It's a bit worrisome if their previous revenues of 100k were generated by their product Colonsentry. Even after developing Aristotle, why would I expect them to generate millions in sales? I understand it detects up 10 cancers from a blood test, but if they don't have a good sales plan, it could be a total flop like Colonsentry. Why didn't Colonsentry ever pick up in sales over the years? Not sure how I feel. I'm gonna risk a decent amount here, but a lot less than I initially planned.